TSY-310
Solid tumors (bispecific ADC)
DevelopmentActive
Key Facts
About Formosa Pharmaceuticals
A clinical-stage biotech company developing ophthalmology and oncology therapies using its proprietary APNT® nanoparticle platform and ADC technology.
View full company profile